BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pau CT, Mosbruger T, Saxena R, Welt CK. Phenotype and Tissue Expression as a Function of Genetic Risk in Polycystic Ovary Syndrome. PLoS One 2017;12:e0168870. [PMID: 28068351 DOI: 10.1371/journal.pone.0168870] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Censin JC, Bovijn J, Holmes MV, Lindgren CM. Colocalization analysis of polycystic ovary syndrome to identify potential disease-mediating genes and proteins. Eur J Hum Genet 2021;29:1446-54. [PMID: 33664499 DOI: 10.1038/s41431-021-00835-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 McAllister JM, Han AX, Modi BP, Teves ME, Mavodza GR, Anderson ZL, Shen T, Christenson LK, Archer KJ, Strauss JF. miRNA Profiling Reveals miRNA-130b-3p Mediates DENND1A Variant 2 Expression and Androgen Biosynthesis. Endocrinology 2019;160:1964-81. [PMID: 31184707 DOI: 10.1210/en.2019-00013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
3 Harper JC, Aittomäki K, Borry P, Cornel MC, de Wert G, Dondorp W, Geraedts J, Gianaroli L, Ketterson K, Liebaers I, Lundin K, Mertes H, Morris M, Pennings G, Sermon K, Spits C, Soini S, van Montfoort APA, Veiga A, Vermeesch JR, Viville S, Macek M Jr; European Society of Human Reproduction and Embryology and European Society of Human Genetics. Recent developments in genetics and medically-assisted reproduction: from research to clinical applications†‡. Hum Reprod Open 2017;2017:hox015. [PMID: 31486804 DOI: 10.1093/hropen/hox015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
4 Xie Y, Xiao L, Li S. Effects of Metformin on Reproductive, Endocrine, and Metabolic Characteristics of Female Offspring in a Rat Model of Letrozole-Induced Polycystic Ovarian Syndrome With Insulin Resistance. Front Endocrinol (Lausanne) 2021;12:701590. [PMID: 34484117 DOI: 10.3389/fendo.2021.701590] [Reference Citation Analysis]
5 Nilsson E, Benrick A, Kokosar M, Krook A, Lindgren E, Källman T, Martis MM, Højlund K, Ling C, Stener-victorin E. Transcriptional and Epigenetic Changes Influencing Skeletal Muscle Metabolism in Women With Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism 2018;103:4465-77. [DOI: 10.1210/jc.2018-00935] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
6 Tian Y, Li J, Su S, Cao Y, Wang Z, Zhao S, Zhao H. PCOS-GWAS Susceptibility Variants in THADA, INSR, TOX3, and DENND1A Are Associated With Metabolic Syndrome or Insulin Resistance in Women With PCOS. Front Endocrinol (Lausanne) 2020;11:274. [PMID: 32425888 DOI: 10.3389/fendo.2020.00274] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Zeber-Lubecka N, Hennig EE. Genetic Susceptibility to Joint Occurrence of Polycystic Ovary Syndrome and Hashimoto's Thyroiditis: How Far Is Our Understanding? Front Immunol 2021;12:606620. [PMID: 33746952 DOI: 10.3389/fimmu.2021.606620] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Abbott DH, Kraynak M, Dumesic DA, Levine JE. In utero Androgen Excess: A Developmental Commonality Preceding Polycystic Ovary Syndrome? Front Horm Res 2019;53:1-17. [PMID: 31499494 DOI: 10.1159/000494899] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
9 Li Y, Xu X, Deng M, Zou X, Zhao Z, Huang S, Liu D, Liu G. Identification and Comparative Analysis of Long Non-coding RNAs in High- and Low-Fecundity Goat Ovaries During Estrus. Front Genet 2021;12:648158. [PMID: 34249080 DOI: 10.3389/fgene.2021.648158] [Reference Citation Analysis]
10 Kadye R, Stoffels M, Fanucci S, Mbanxa S, Prinsloo E. A STAT3 of Addiction: Adipose Tissue, Adipocytokine Signalling and STAT3 as Mediators of Metabolic Remodelling in the Tumour Microenvironment. Cells 2020;9:E1043. [PMID: 32331320 DOI: 10.3390/cells9041043] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
11 Hiam D, Moreno-Asso A, Teede HJ, Laven JSE, Stepto NK, Moran LJ, Gibson-Helm M. The Genetics of Polycystic Ovary Syndrome: An Overview of Candidate Gene Systematic Reviews and Genome-Wide Association Studies. J Clin Med 2019;8:E1606. [PMID: 31623391 DOI: 10.3390/jcm8101606] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
12 Harper JC, Aittomäki K, Borry P, Cornel MC, de Wert G, Dondorp W, Geraedts J, Gianaroli L, Ketterson K, Liebaers I, Lundin K, Mertes H, Morris M, Pennings G, Sermon K, Spits C, Soini S, van Montfoort APA, Veiga A, Vermeesch JR, Viville S, Macek M Jr; on behalf of the European Society of Human Reproduction and Embryology and European Society of Human Genetics. Recent developments in genetics and medically assisted reproduction: from research to clinical applications. Eur J Hum Genet 2018;26:12-33. [PMID: 29199274 DOI: 10.1038/s41431-017-0016-z] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 8.4] [Reference Citation Analysis]
13 Moretti C, Guccione L, Di Giacinto P, Simonelli I, Exacoustos C, Toscano V, Motta C, De Leo V, Petraglia F, Lenzi A. Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial. The Journal of Clinical Endocrinology & Metabolism 2018;103:824-38. [DOI: 10.1210/jc.2017-01186] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
14 Bruni V, Capozzi A, Lello S. The Role of Genetics, Epigenetics and Lifestyle in Polycystic Ovary Syndrome Development: the State of the Art. Reprod Sci . [DOI: 10.1007/s43032-021-00515-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Abbott DH, Dumesic DA, Levine JE. Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy. Expert Rev Endocrinol Metab 2019;14:131-43. [PMID: 30767580 DOI: 10.1080/17446651.2019.1576522] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 12.7] [Reference Citation Analysis]
16 Bohaczuk SC, Thackray VG, Shen J, Skowronska-Krawczyk D, Mellon PL. FSHB  Transcription is Regulated by a Novel 5' Distal Enhancer With a Fertility-Associated Single Nucleotide Polymorphism. Endocrinology 2021;162:bqaa181. [PMID: 33009549 DOI: 10.1210/endocr/bqaa181] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
17 Liu M, Hummitzsch K, Hartanti MD, Rosario R, Bastian NA, Hatzirodos N, Bonner WM, Irving-Rodgers HF, Laven JSE, Anderson RA, Rodgers RJ. Analysis of expression of candidate genes for polycystic ovary syndrome in adult and fetal human and fetal bovine ovaries†. Biol Reprod 2020;103:840-53. [PMID: 32678441 DOI: 10.1093/biolre/ioaa119] [Reference Citation Analysis]
18 Khan MJ, Nazli R, Ahmed J, Basit S. Whole Genome Sequencing instead of Whole Exome Sequencing is required to identify the Genetic Causes of Polycystic Ovary Syndrome in Pakistani families. Pak J Med Sci 2018;34:540-5. [PMID: 30034412 DOI: 10.12669/pjms.343.14644] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
19 Dadachanji R, Sawant D, Patil A, Mukherjee S. Replication study of THADA rs13429458 variant with PCOS susceptibility and its related traits in Indian women. Gynecol Endocrinol 2021;37:716-20. [PMID: 33779462 DOI: 10.1080/09513590.2021.1906854] [Reference Citation Analysis]
20 Trevino CE, Rounds JC, Charen K, Shubeck L, Hipp HS, Spencer JB, Johnston HR, Cutler DJ, Zwick ME, Epstein MP, Murray A, Macpherson JN, Mila M, Rodriguez-Revenga L, Berry-Kravis E, Hall DA, Leehey MA, Liu Y, Welt C, Warren ST, Sherman SL, Jin P, Allen EG. Identifying susceptibility genes for primary ovarian insufficiency on the high-risk genetic background of a fragile X premutation. Fertil Steril 2021;116:843-54. [PMID: 34016428 DOI: 10.1016/j.fertnstert.2021.04.021] [Reference Citation Analysis]